Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas

Masao Tanaka, Carlos Fernández-del Castillo, Terumi Kamisawa, Jin Young Jang, Philippe Levy, Takao Ohtsuka, Roberto Salvia, Yasuhiro Shimizu, Minoru Tada, Christopher Wolfgang

Research output: Contribution to journalArticle

Abstract

The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In particular, the indications for resection of branch duct IPMN have changed from early resection to more deliberate observation as proposed by the international consensus guidelines of 2006 and 2012. Another guideline proposed by the American Gastroenterological Association in 2015 restricted indications for surgery more stringently and recommended physicians to stop surveillance if no significant change had occurred in a pancreatic cyst after five years of surveillance, or if a patient underwent resection and a non-malignant IPMN was found. Whether or not it is safe to do so, as well as the method and interval of surveillance, has generated substantial debate. Based on a consensus symposium held during the meeting of the International Association of Pancreatology in Sendai, Japan, in 2016, the working group has revised the guidelines regarding prediction of invasive carcinoma and high-grade dysplasia, surveillance, and postoperative follow-up of IPMN. As the working group did not recognize the need for major revisions of the guidelines, we made only minor revisions and added most recent articles where appropriate. The present guidelines include updated information and recommendations based on our current understanding, and highlight issues that remain controversial or where further research is required.

Original languageEnglish (US)
JournalPancreatology
DOIs
StateAccepted/In press - 2017

Fingerprint

Pancreatic Neoplasms
Guidelines
Neoplasms
Pancreatic Cyst
Japan
Observation
Carcinoma
Physicians
Research

Keywords

  • International guidelines
  • Intraductal papillary mucinous neoplasm
  • Pancreatic cancer
  • Surveillance

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Tanaka, M., Fernández-del Castillo, C., Kamisawa, T., Jang, J. Y., Levy, P., Ohtsuka, T., ... Wolfgang, C. (Accepted/In press). Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. https://doi.org/10.1016/j.pan.2017.07.007

Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. / Tanaka, Masao; Fernández-del Castillo, Carlos; Kamisawa, Terumi; Jang, Jin Young; Levy, Philippe; Ohtsuka, Takao; Salvia, Roberto; Shimizu, Yasuhiro; Tada, Minoru; Wolfgang, Christopher.

In: Pancreatology, 2017.

Research output: Contribution to journalArticle

Tanaka, M, Fernández-del Castillo, C, Kamisawa, T, Jang, JY, Levy, P, Ohtsuka, T, Salvia, R, Shimizu, Y, Tada, M & Wolfgang, C 2017, 'Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas', Pancreatology. https://doi.org/10.1016/j.pan.2017.07.007
Tanaka, Masao ; Fernández-del Castillo, Carlos ; Kamisawa, Terumi ; Jang, Jin Young ; Levy, Philippe ; Ohtsuka, Takao ; Salvia, Roberto ; Shimizu, Yasuhiro ; Tada, Minoru ; Wolfgang, Christopher. / Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. In: Pancreatology. 2017.
@article{f877ff2bdd6e4a60ad5286f290ea6c48,
title = "Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas",
abstract = "The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In particular, the indications for resection of branch duct IPMN have changed from early resection to more deliberate observation as proposed by the international consensus guidelines of 2006 and 2012. Another guideline proposed by the American Gastroenterological Association in 2015 restricted indications for surgery more stringently and recommended physicians to stop surveillance if no significant change had occurred in a pancreatic cyst after five years of surveillance, or if a patient underwent resection and a non-malignant IPMN was found. Whether or not it is safe to do so, as well as the method and interval of surveillance, has generated substantial debate. Based on a consensus symposium held during the meeting of the International Association of Pancreatology in Sendai, Japan, in 2016, the working group has revised the guidelines regarding prediction of invasive carcinoma and high-grade dysplasia, surveillance, and postoperative follow-up of IPMN. As the working group did not recognize the need for major revisions of the guidelines, we made only minor revisions and added most recent articles where appropriate. The present guidelines include updated information and recommendations based on our current understanding, and highlight issues that remain controversial or where further research is required.",
keywords = "International guidelines, Intraductal papillary mucinous neoplasm, Pancreatic cancer, Surveillance",
author = "Masao Tanaka and {Fern{\'a}ndez-del Castillo}, Carlos and Terumi Kamisawa and Jang, {Jin Young} and Philippe Levy and Takao Ohtsuka and Roberto Salvia and Yasuhiro Shimizu and Minoru Tada and Christopher Wolfgang",
year = "2017",
doi = "10.1016/j.pan.2017.07.007",
language = "English (US)",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas

AU - Tanaka, Masao

AU - Fernández-del Castillo, Carlos

AU - Kamisawa, Terumi

AU - Jang, Jin Young

AU - Levy, Philippe

AU - Ohtsuka, Takao

AU - Salvia, Roberto

AU - Shimizu, Yasuhiro

AU - Tada, Minoru

AU - Wolfgang, Christopher

PY - 2017

Y1 - 2017

N2 - The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In particular, the indications for resection of branch duct IPMN have changed from early resection to more deliberate observation as proposed by the international consensus guidelines of 2006 and 2012. Another guideline proposed by the American Gastroenterological Association in 2015 restricted indications for surgery more stringently and recommended physicians to stop surveillance if no significant change had occurred in a pancreatic cyst after five years of surveillance, or if a patient underwent resection and a non-malignant IPMN was found. Whether or not it is safe to do so, as well as the method and interval of surveillance, has generated substantial debate. Based on a consensus symposium held during the meeting of the International Association of Pancreatology in Sendai, Japan, in 2016, the working group has revised the guidelines regarding prediction of invasive carcinoma and high-grade dysplasia, surveillance, and postoperative follow-up of IPMN. As the working group did not recognize the need for major revisions of the guidelines, we made only minor revisions and added most recent articles where appropriate. The present guidelines include updated information and recommendations based on our current understanding, and highlight issues that remain controversial or where further research is required.

AB - The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In particular, the indications for resection of branch duct IPMN have changed from early resection to more deliberate observation as proposed by the international consensus guidelines of 2006 and 2012. Another guideline proposed by the American Gastroenterological Association in 2015 restricted indications for surgery more stringently and recommended physicians to stop surveillance if no significant change had occurred in a pancreatic cyst after five years of surveillance, or if a patient underwent resection and a non-malignant IPMN was found. Whether or not it is safe to do so, as well as the method and interval of surveillance, has generated substantial debate. Based on a consensus symposium held during the meeting of the International Association of Pancreatology in Sendai, Japan, in 2016, the working group has revised the guidelines regarding prediction of invasive carcinoma and high-grade dysplasia, surveillance, and postoperative follow-up of IPMN. As the working group did not recognize the need for major revisions of the guidelines, we made only minor revisions and added most recent articles where appropriate. The present guidelines include updated information and recommendations based on our current understanding, and highlight issues that remain controversial or where further research is required.

KW - International guidelines

KW - Intraductal papillary mucinous neoplasm

KW - Pancreatic cancer

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=85025443370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025443370&partnerID=8YFLogxK

U2 - 10.1016/j.pan.2017.07.007

DO - 10.1016/j.pan.2017.07.007

M3 - Article

C2 - 28735806

AN - SCOPUS:85025443370

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

ER -